Objective To examine circulating levels of inter-alpha inhibitor protein (IaIp) in infants with necrotizing enterocolitis (NEC), spontaneous intestinal perforation (SIP), and matched controls to assess the diagnostic accuracy of IaIp to differentiate NEC from SIP and to compare receiver operating characteristics of IaIp for NEC with C-reactive protein (CRP).
Conclusions IaIp levels were significantly decreased in infants with NEC compared with SIP and matched controls. The diagnostic accuracy of IaIp for NEC was superior to that of CRP. (J Pediatr 2017; 180:135-40) .
N ecrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP) are important causes of high morbidity and mortality in infants with very low birth weight. [1] [2] [3] Neurodevelopmental impairment among survivors is substantial in both and worse for infants with surgical NEC compared with SIP. 3 NEC affects 7%-10% of infants with very low birth weight. 1, 2 Early and accurate diagnosis of NEC in preterm infants remains a major challenge in neonatology because its clinical features, for example, abdominal distention and bloody stools, can be nonspecific and indistinguishable from SIP and other gastrointestinal disorders. 2 The diagnosis traditionally is established radiographically (ie, pneumatosis intestinalis); however, there is significant interobserver variability in interpreting abdominal films of neonates with clinically suspected NEC. 4 Although the exact cause of NEC is still unclear, it is widely accepted that the pathogenesis of NEC includes mucosal injury with subsequent bacterial translocation across the intestinal epithelial layer and dysregulation of innate immune defenses leading to subsequent inflammation and tissue necrosis. 2 SIP mainly affects infants with extremely low birth weight at an early postnatal age. 5, 6 SIP is characterized as an isolated perforation without surrounding necrosis or neutrophil infiltrate, often accompanied by a focal thinning or absence of the intestinal muscularis propria. 7, 8 The pathophysiology of SIP is poorly understood. Studies to date are mixed on whether postnatal corticosteroids and/or nonsteroidal anti-inflammatory agents are associated with SIP. [9] [10] [11] Affected infants have relative clinical stability in the early stages, lacking systemic signs and symptoms of severe illness. 12 They do not have radiologic features of pneumatosis intestinalis and portal venous gas as seen in NEC.
Despite these differences, NEC and SIP are treated similarly, partly because of the inability to distinguish between them preoperatively, as early clinical signs and symptoms are nonspecific and overlapping. 13 Differentiating NEC from SIP would advance our understanding of these disorders and be clinically useful to assist in institutional antibiotic stewardship efforts and in identifying infants who might benefit from novel and specific therapies.
There is a paucity of data on biomarkers to distinguish NEC from SIP. C-reactive protein (CRP) has been shown to be increased inconsistently in NEC, but no studies
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14 The inter-alpha inhibitor proteins (IaIps) are serine protease inhibitors secreted by the liver. 15 Two forms of IaIp are found in blood: inter-alpha inhibitor, a heterotrimeric, 250-kDa protein complex composed of 2 heavy chains and 1 light chain held together by glycosaminoglycan bonds and pre-alpha inhibitor, a heterodimeric, 125-kDa protein complex composed of 1 heavy and 1 light chain. 16 The light chain, bikunin, has a molecular weight of 30 kDa and is the active, antiprotease component. 17 The half-life of bikunin is very short and it is excreted rapidly by the kidneys. IaIp have been shown to be decreased in neonatal sepsis and NEC. 18, 19 The current nested case-control study prospectively measured the circulating IaIp levels in infants with NEC, SIP, and controls. Our a priori hypotheses were that IaIp distinguishes infants with NEC from SIP and controls and that IaIp is superior to CRP for the early detection of NEC.
Methods
This nested case-control study was conducted at Women & Infants Hospital of Rhode Island from December 2012 to March 2015 after approval from the institutional review board. All liveborn infants admitted to the neonatal intensive care unit were screened for feeding intolerance as evidenced by abdominal distention, abdominal tenderness, presence of blood in stool and/or increased gastric residuals (more than one-half the volume of feeds over the previous 3 hours) resulting in cessation of feedings, performance of abdominal radiographs, and blood sampling for complete blood count and blood cultures. 20, 21 Exclusion criteria included decision made for comfort care only, major congenital anomalies, and genetic syndromes. Subsequently, infants were enrolled following written informed parental consent. Three of the eligible families did not consent to participate in the study, and no significant differences emerged between enrolled families and those that did not consent.
Infants with stage 2 or greater (modified Bell criteria) were included as NEC. 2 All of the cases with NEC had pneumatosis intestinalis. An independent pediatric radiologist who was unaware of the group assignment interpreted all abdominal radiographs. Pneumoperitoneum alone or bowel contents in the peritoneum after placement of an intraperitoneal drain in otherwise-stable infants that the attending neonatologist and attending surgeon classified as SIP and not NEC based on clinical, radiographic, and/or surgical finding were included as SIP. 13 Controls were infants who presented with nonspecific abdominal findings as described previously and were limited to Bell stage 1 (cession of feedings and/or antibiotics ≤2 days). Controls were matched for gestational age at birth ± 2 weeks, postnatal age ± 1 week, sex, and birth weight ± 500 g.
Maternal and infant clinical characteristics were recorded (Tables I and II). Bronchopulmonary dysplasia was defined as receipt of supplemental oxygen or continuous positive airway pressure at 36 weeks' postmenstrual age or death. The Score for Neonatal Acute Physiology Perinatal Extension II (SNAPPE-II) was used, because it has been shown to be a good predictor of mortality with area under the curve by using the receiver operating characteristic (ROC) analysis of 0.85 (95% CI 0.79-0.97). 22 All the physiological, laboratory, and therapy data for the first 12 hours after birth were collected prospectively to calculate SNAPPE-II, and the most aberrant values were used for scoring. The staff who collected the data from electronic medical records underwent training for consistency in recording into the database.
Circulating IaIp levels were measured quantitatively on residual blood obtained at the initial presentation. Blood was collected in tubes (Becton Dickinson Microtainer Systems, Franklin Lakes, New Jersey) containing EDTA for plasma or in plain tubes without anticoagulant for serum. The contents of collection tubes without anticoagulant were allowed to clot at room temperature for 30 minutes. Serum and plasma were separated by centrifuging at 1000-2000g for 10 minutes with the use of a refrigerated centrifuge and immediately transferred into a clean polypropylene tube. The samples were maintained at 2-8°C while handling and frozen at −70°C during storage. Archived blood samples were thawed at room temperature to measure IaIp. We measured IaIp on all residual samples that were available 7-10 days before and all samples after the initial diagnosis for longitudinal analysis. We used a competitive, enzyme-linked immunosorbent assay with a monoclonal antibody against human IaIp (monoclonal antibody 69.26), as described previously. 23 The assay has a sensitivity or lower limit of detection of 50 mg/L and a linear dynamic range of up to 750 mg/L. The intra-assay variability (coefficient of variation) is <3%, and the interassay coefficient of variation is <7%. 18 Previous studies have demonstrated that the IaIp levels are stable under the conditions of collection and storage used in this study. 11, 12 CRP levels were measured in duplicate serum samples via the Quantikine enzyme-linked immunosorbent assay (R&D Systems Inc, Minneapolis, Minnesota). The staff who performed these assays were masked to the sample identity.
The sensitivity, specificity, positive, and negative predictive value for IaIp and CRP in diagnosis of NEC were determined by ROC analysis (MedCalc version 15.2.1, MedCalc Software, Ostend, Belgium; www.medcalc.be). The relationship between circulating IaIp and SNAPPE-II scores was assessed with Spearman correlation. Data analyses also included 1-way ANOVA and post-hoc Student-Newman-Keuls test for continuous variables. c 2 test was performed for categorical variables as appropriate. Statistical calculations were performed using Statistica (StatSoft, Tulsa, Oklahoma) with P < .05 significant.
Results
During the study period, a total of 1934 neonates were admitted to the neonatal intensive care unit. Of these, 14 infants had a confirmed diagnosis of NEC (10 with Bell stage II and 4 with Bell stage III), 13 infants had SIP, and 26 infants were enrolled as matched controls. Table I shows the maternal demographic and clinical variables. There were no significant differences between the 3 groups in maternal age, race, prenatal care, hypertension, THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 180 insulin-dependent diabetes mellitus, prolonged rupture of membranes, histologic chorioamnionitis, antibiotics, antenatal steroids, and breastfeeding. Table II shows the clinical characteristics of the infant study population. The mean ± SD corrected gestational age for initial presentation of NEC in our study was 29.6 ± 2 weeks. The infants with SIP had lower mean gestational age and birth weight than others. They also had a mean day of initiation of feeds that was later than that for the other groups and greater days on parenteral nutrition, but these differences were not statistically significant. The majority of infants with SIP had not been fed or had only recently initiated feedings. There were significantly more infants who received initial antibiotic treatment for more than 48 hours in the group with SIP compared with NEC and controls. There also were significant differences among the 3 groups in culture-proven sepsis, age at initiation of enteral feeds, duration of parenteral nutrition, and the incidence of retinopathy of prematurity.
Compared with the group with SIP (276 ± 67 mg/L) and matched controls (330 ± 100 mg/L), mean ± SD circulating IaIp levels were significantly lower in infants with NEC (147 ± 38 mg/L) at the time of initial presentation (P < .004 and P < .01) (Figure 1 ). Blood levels of IaIp remained significant on subgroup analysis of the infants with diagnosis established by tissue pathology (P < .05). CRP levels were not statistically different among the 3 groups (P > .05). There were no statistically significant differences in blood levels of IaIp between NEC Bell stage II and stage III (P > .05).
ROC analysis for NEC yielded an area under the curve of 0.98 (P < .0001, 95% CI 0.84-0.99) with a sensitivity of 100%, specificity of 88.2%, positive predictive value of 41%, and a negative predictive value of 100% for IaIp (<207 mg/L); the area under the curve for CRP (<4 mg/L) was 0.65 (P = .01, 95% CI 0.54-0.90) with a sensitivity of 100%, specificity of 64.7%, positive predictive value of 18.7%, and negative predictive value of 98% (Figure 2) .
The mean ± SD IaIp levels in blood after initial presentation were significantly lower in infants with NEC compared with infants with SIP (P < .05) (Figure 3 ; available at www.jpeds.co,). We also found a significant negative correlation between circulating IaIp levels at disease presentation and SNAPPE-II scores (first 12 hours of life) in all infants studied (r = −0.32, P < .05) (Figure 4 ; available at www.jpeds.com).
Discussion
This study reports the circulating IaIp levels in infants with NEC, SIP, and matched controls evaluated prospectively and longitudinally. Circulating IaIp levels were significantly reduced in infants with NEC compared with infants with SIP and controls with feeding intolerance at presentation, followed by a gradual increase during subsequent therapy to normal levels when measured serially. These data demonstrate a striking difference in the degree of innate immune system dysregulation (lower IaIp levels) associated with NEC.
IaIp are endogenous serine protease inhibitors found in human plasma at relatively high concentrations. 23 Their circulating levels are independent of gestational age, postnatal age, and are similar to adult levels. 19 They are reduced significantly in patients with sepsis in both adults and neonates. 19, 23 IaIp are considered negative acute-phase proteins 24 that, as part of the innate immune response, protect against the damaging effects of proteases released during acute systemic inflammation following severe infections. 17 As a consequence, these proteins are "consumed" rapidly and excreted in the urine, leading to a rapid decrease in circulatory levels. In addition, in several adult and newborn animal models of sepsis, 14 (100) 13 (100) 26 (100) Cesarean delivery, n (%)
8 (57) 10 (77) 20 (77) PROM, prolonged rupture of membranes. *P < .05. †PROM: >24 h.
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IaIp-replacement therapy has been demonstrated to reverse the decrease in systemic IaIp levels and reduce sepsis-related mortality. [25] [26] [27] [28] [29] At least 3 distinct mechanisms in the inflammatory pathway appear to contribute to the protective role of IaIp: (1) inhibition of destructive serine proteases such as elastase, cathepsin G, and several others 17 ; (2) down-regulation of proinflammatory cytokines such as tumor necrosis factor-a and interleukin-6 25, 26 ; and (3) blocking excess complement activation and generation of circulating C5a. 30 Because NEC is associated with systemic inflammation, IaIps are involved in modulating the host response to systemic immune system activation that 2 (14) 5 (39) 3 (12) Medical treatment, n (%) 1 (7) 1 (8) 2 (8) Surgery ligation, n (%) 1 (7) 0 (0) 0 (0) pRBC transfusion, n (%)
8 (57) 12 (92) 16 (62) Within previous 48 h of presentation, n (%)
2 (14) 3 (23) 1 (4) Length of NICU stay, d, mean ± SD 98 ± 52 110 ± 32 94 ± 45 Death, n (%) 1 (7) 1 (8) 
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Volume 180 accompanies inflammation. More recently, IaIps were shown to bind and inhibit the damaging effects of extracellular histones both in vitro and in vivo. 31 Histones elicit major cytotoxic, thrombotic, and inflammatory effects and serve as dangerassociated molecular patterns/alarmins. 32 This is further supported by studies in IL-10 −/− mice in which newborns housed under nonaseptic conditions develop NEC-like symptoms. 33 Hematologic indices, cytokines, and other mediators have been examined for diagnosis of NEC. Individual markers like serum amyloid A, anaphylatoxin (C5a), urinary intestinal fatty acid-binding protein, claudin-3, stool platelet-activating factor, and calprotectin may support the diagnosis of NEC. [34] [35] [36] [37] Downregulation of micro-RNA such as miR-31 and miR-203 has been proposed to potentiate proinflammatory signaling mediated by bacterial toll-like receptor-4. In contrast, up-regulation of miR-451 and miR-223 in SIP suggests modulation of G-protein-mediated muscle contraction. 38 None of these markers, however, have shown to be reliable and clinically useful.
CRP is an acute phase reactant synthesized by the liver and has a half-life of 24-48 hours. Because it takes 10-12 hours to change significantly after the onset of infection, the sensitivity of CRP is low during the early phase of sepsis. 15 It can be elevated in noninfectious conditions like meconium aspiration syndrome, traumatic or ischemic tissue injuries, hemolysis, or histologic chorioamnionitis. 15 Nonetheless, the association between persistently high levels of CRP and NECrelated complications has been shown. 39 Here we used the unbiased estimate (ROC modeling) of IaIp to determine a cutoff value of <207 mg/L. With this value, assessment of IaIp level would have a robust diagnostic accuracy with a high sensitivity, specificity, and negative predictive value. We also found the diagnostic accuracy of IaIp to be superior to CRP for NEC.
A limitation of this study is the modest sample size. There may be confounders of which we remain unaware. It is also possible that the disease processes start before clinical signs and symptoms develop when the blood samples were collected; however, because there are no reliable biomarkers currently available this is difficult to evaluate. Moreover, serial samples were not available for all infants with NEC and SIP at similar time points. Our study was not powered to distinguish "classic" NEC from the disease that presents within 48 hours of a packed red blood cell transfusion. Finally, the diagnosis of NEC vs SIP was not confirmed histologically in all cases, as 5 infants randomized to bedside peritoneal drain as per the Eunice Kennedy Shriver National Institute of Child Health and Human Development Necrotizing Enterocolitis Surgery Trial. A strength of this study is the prospective, population-based, unbiased collection of samples from all patients in a single, regional center during a defined time period. Moreover, these data may allow for early discrimination of NEC from SIP, which will be an important consideration for proper assignment and follow-up as new clinical therapies are tested.
In summary, we demonstrated IaIp may assist in the early detection of NEC and distinguish NEC from SIP and other, nonspecific abdominal disorders of preterm infants. We confirmed that circulating IaIp levels were decreased significantly in patients with NEC. As a biomarker, this distinction at presentation may lead to earlier effective treatments and improved outcomes. Because IaIp correlated with disease progression when measured serially, it may serve as a surrogate to monitor response to therapy in NEC. Further multicenter studies with large sample sizes are needed to validate these findings in other populations. ■ Figure 3 . Serial circulating IaIp levels in infants with NEC and SIP (n = 128). Figure 4 . Circulating IaIp at disease presentation negatively correlated with SNAPPE-II (first 12 hours of life) in infants with NEC (n = 14), SIP (n = 13), and matched controls (n = 26).
